HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

被引：0
|
作者：
Yvonne N. Flores
David M. Bishai
Attila Lőrincz
Keerti V. Shah
Eduardo Lazcano-Ponce
Mauricio Hernández
Víctor Granados-García
Ruth Pérez
Jorge Salmerón
机构：
[1] Instituto Mexicano del Seguro Social,Unidad de Investigación Epidemiológica y en Servicios de Salud
[2] Johns Hopkins University,Department of Population, Family, and Reproductive Health
[3] Bloomberg School of Public Health,Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine
[4] Queen Mary University of London,Department of Molecular Microbiology and Immunology
[5] Johns Hopkins University,Centro de Investigación en Salud Poblacional
[6] Bloomberg School of Public Health,Secretaria de Prevención y Promoción de la Salud
[7] Instituto Nacional de Salud Pública,Unidad de Investigación en Economía de la Salud
[8] Secretaría de Salud,Departamento de Abastecimiento, Instituto Mexicano del Seguro Social
[9] Instituto Mexicano del Seguro Social,undefined
[10] Hospital General Regional No. 1,undefined
来源：
Cancer Causes & Control | 2011年 / 22卷
关键词：
Cost-effectiveness; Cervical cancer; HPV; Screening; Mexico;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：261 / 272
页数：11
相关论文
共 50 条
  • [1] HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
    Flores, Yvonne N.
    Bishai, David M.
    Lorincz, Attila
    Shah, Keerti V.
    Lazcano-Ponce, Eduardo
    Hernandez, Mauricio
    Granados-Garcia, Victor
    Perez, Ruth
    Salmeron, Jorge
    CANCER CAUSES & CONTROL, 2011, 22 (02) : 261 - 272
  • [2] Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country
    Vale, Diama Bhadra
    Silva, Marcus Tolentino
    Discacciati, Michelle Garcia
    Polegatto, Ilana
    Teixeira, Julio Cesar
    Zeferino, Luiz Carlos
    PLOS ONE, 2021, 16 (05):
  • [3] HPV testing 'prevents more cervical cancers than cytology'
    不详
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) : 686 - 686
  • [4] Screening for cervical cancer using primary human papillomavirus testing and reflex cytology: A cost-effective analysis
    Schuman, S.
    Barbee, L.
    Papadia, A.
    Jimenez, E. A.
    Khanna, N.
    Mckenzie, N.
    Lucci, J. A.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S19 - S19
  • [5] Is proof more cost-effective than testing?
    King, S
    Hammond, J
    Chapman, R
    Pryor, A
    IEEE TRANSACTIONS ON SOFTWARE ENGINEERING, 2000, 26 (08) : 675 - 686
  • [6] HPV DNA testing detects more cervical lesions than cytology
    Nature Reviews Clinical Oncology, 2013, 10 (2) : 64 - 64
  • [7] Cervical cytology: Still the most cost-effective cervical carcinoma screening test?
    Raab, S.
    ACTA CYTOLOGICA, 2007, 51 (02) : 263 - 263
  • [8] Cervical cancer screening in Denmark: can cervical cancer screening be cost-effective?
    Lynge, E
    NEW INSIGHTS IN GYNECOLOGY & OBSTETRICS: RESEARCH AND PRACTICE, 1998, : 251 - 256
  • [9] Visual inspection with acetic acid is more cost-effective than pap smears for cervical cancer screening in Honduras
    Perkins, Rebecca
    Langrish, Sarah
    Stern, Linda
    Figueroa, Jaqueline
    Simon, Carol
    JOURNAL OF WOMENS HEALTH, 2007, 16 (08) : 1111 - 1112
  • [10] Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia
    Andres-Gamboa, Oscar
    Chicaiza, Liliana
    Garcia-Molina, Mario
    Diaz, Jorge
    Gonzalez, Mauricio
    Murillo, Raul
    Ballesteros, Monica
    Sanchez, Ricardo
    SALUD PUBLICA DE MEXICO, 2008, 50 (04): : 276 - 285
12345